In our pursuit to unlock the complexities of the human proteome and fully harness its potential for groundbreaking biomedical advancements, we are proud to introduce the π-HuB Project (Proteomic Navigator of the Human Body). This ambitious scientific initiative aims to develop an advanced computational engine—the π-HuB Navigator—designed to integrate and analyze multi-modal proteomic datasets. By doing so, we seek to deepen our understanding of human biology, facilitate more accurate disease risk assessments and diagnoses, uncover novel drug targets, optimize therapeutic strategies, and ultimately drive the future of intelligent healthcare solutions.This transformative mission will and only be realized through a collaborative international effort, engaging multidisciplinary research teams from academia, industry, and government sectors across the globe.

Introduction to the Seed Program: Aligned with the π-HuB Project's mission to pioneer proteomics-driven precision medicine, we proudly introduce the Seed Program. This initiative leverages the robust resources of the π-HuB Project's international headquarters core support platform in Guangzhou, China. Since its inception in 2021, the program has endeavored to create multidimensional proteomic maps from clinical cohorts, both locally and globally, to identify diagnostic markers, therapeutic targets, and delve into the mechanisms of disease pathogenesis.

The 12th CNHUPO Congress & The π-HuB Project Global Summit will be held in Chengdu, China from 25th-27th of September 2023

Joint 11th AOHUPO and 7th AOAPO Congress: 2023.5.8-10, Singapore